Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors: Please contact the Portnoy Law Firm to recover your losses


Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Eagle stock. Eagle investors are encouraged to contact the firm to discuss their legal rights.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On November 9, 2023, Eagle Pharmaceuticals announced a delay in filing their financial report for the quarter ending September 30, 2023. The company cited the need for additional time to review potential adjustments related to the sales reporting of PEMFEXY® as the primary reason for this delay. Subsequently, on November 29, 2023, Eagle disclosed that its CEO, Scott Tarriff, had resigned effective immediately. The board accepted his resignation, and the separation agreement included clawback provisions. These provisions would allow the board to retrieve or annul any payments made to Tariff if it was found that he engaged in any behavior constituting "cause" under his employment contract.

As of the current date, Eagle has yet to file its Form 10-Q. Consequently, the company received a notice of deficiency from Nasdaq due to this failure. These series of events have significantly impacted Eagle's stock, resulting in a notable decline in the share price.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising